Pixium Vision SA, a bioelectronics and brain machine interface technology company, specialized in neuromodulation application. It develops PRIMA System, a bionic vision system for patients with severe vision loss due to retinal degeneration caused by the dry atrophic form of Age-related Macular Degeneration (AMD); and to treat bilndness, which replace the normal physiological function of the eye's photoreceptor cells by electrically stimulating the nerve cells of the inner retina, which then transmit the visual information to the brain via the optic nerve. The company has collaboration agreements with Stanford University in California, Institut de la Vision, Moorfields Eye Hospital, Institute of Ocular Microsurgery, University Hospital, and UPMC. Pixium Vision SA was founded in 2011 and is based in Paris, France.

Pixium Vision SA

Beverly Hills Institute of Ophthalmology provides ophthalmology services including LASIK surgery, cataract surgery, and comprehensive eye care. The institute is described as having advanced technology and a team of experienced ophthalmologists.

Beverly Hills Institute of Ophthalmology

APSYS MEDICAL provides advanced technology for ophthalmic surgery.

APSYS MEDICAL

Eye Institute of Austin provides ophthalmology services, including evaluations and treatments for various eye conditions and surgical procedures. The institute has a self-described commitment to exceptional service and community eye health.

Eye Institute of Austin

Pixium Vision SA is involved in clinical trials related to late-stage macular degeneration. Self-described assets have been acquired by Science Corporation.

Metric
Company Name	Pixium Vision SA	Beverly Hills Institute of Ophthalmology	APSYS MEDICAL	Eye Institute of Austin
Symbol	ALPIX
MSH ID	COM:PIXIUM-VISION	COM:90210EYES	COM:APSYS-MEDICAL	COM:EYEINSTITUTE
Market	STOCKS	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare	Healthcare & Health Services	Healthcare & Health Services	Healthcare & Health Services
Industry	Medical - Instruments & Supplies	Medical Services	Medical Devices	Medical Practice
Country	FR	US	FR	US
Stage
Employee Count	40
Website	pixium-vision.com	90210eyes.com	apsys-medical.com	eyeinstitute.com
LinkedIn
Founders

Metric
Market Cap	1.22M
Enterprise Value
Monthly Web Traffic		1.12K
Web Traffic Growth		-0.61
Valuation
Raised Capital

Metric
Revenue	2.11K
Revenue (LTM)
Revenue (NTM)
Gross Profit	2.11K
EBITDA	-10.55M
Operating Income	-12.62M
Net Income	-10.11M
EPS	-0.21
Diluted EPS	-0.21
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.55
Operating Profit Margin	-10.61
EBITDA Margin	-5.00K
Net Profit Margin	-8.77
Return on Equity	3.49
Return on Assets	-1.97
Return on Capital Employed	96.26

ALPI

COM:PIXIUM-VISION

Pixium Vision SA

Last Close

0.42

30/01 16:35

Market Cap

1.16M

Beta: -

Volume Today

86.01K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	-1.92
P/B Ratio	-6.46
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	0.86
EV Multiple	0.24

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle	300.06
Cash Conversion Cycle	-555.14
Asset Turnover	0.26

Metric
Operating Cash Flow	-11.96M
Free Cash Flow	-12.06M
Cash Flow to Debt	-1.25
Operating Cash Flow/Sales	-6.85
Free Cash Flow Yield	-7.44

Metric
Cash & Equivalents	8.12M
Accounts Receivable	-229.20K
Inventory
Goodwill
Debt to Capitalization	4.25
Debt to Assets	0.90
Current Ratio	1.19
Quick Ratio	0.69

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	69.50
R&D to Revenue	2.00K
SG&A to Revenue	169.75